A carregar...

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar

BACKGROUND: Etanercept is prescribed for the rapid and effective treatment of chronic immune-mediated inflammatory disorders. Due to the expiration of etanercept patents and worldwide demand for comparable and more affordable substitutes, several biosimilars of etanercept have been approved in diffe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Iran J Biotechnol
Main Authors: Fazel, Ramin, Mahboudi, Fereidoun, Seyedjafari, Ehsan, Sardari, Soroush, Vaziri, Behrouz
Formato: Artigo
Idioma:Inglês
Publicado em: National Institute of Genetic Engineering and Biotechnology 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357702/
https://ncbi.nlm.nih.gov/pubmed/32671128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.30498/IJB.2019.99581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!